- Home
- GROV vs ASRT Comparison
GROV vs ASRT Comparison
Compare GROV & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- ASRT
- Stock Information
- Founded
- GROV 2016
- ASRT 1995
- Country
- GROV United States
- ASRT United States
- Employees
- GROV N/A
- ASRT N/A
- Industry
- GROV Package Goods/Cosmetics
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- ASRT Health Care
- Exchange
- GROV Nasdaq
- ASRT Nasdaq
- Market Cap
- GROV 59.0M
- ASRT 65.7M
- IPO Year
- GROV N/A
- ASRT 1997
- Fundamental
- Price
- GROV $1.11
- ASRT $0.61
- Analyst Decision
- GROV Buy
- ASRT Strong Buy
- Analyst Count
- GROV 1
- ASRT 3
- Target Price
- GROV $2.00
- ASRT $3.08
- AVG Volume (30 Days)
- GROV 108.3K
- ASRT 480.8K
- Earning Date
- GROV 05-13-2025
- ASRT 05-05-2025
- Dividend Yield
- GROV N/A
- ASRT N/A
- EPS Growth
- GROV N/A
- ASRT N/A
- EPS
- GROV N/A
- ASRT N/A
- Revenue
- GROV $203,425,000.00
- ASRT $124,961,000.00
- Revenue This Year
- GROV N/A
- ASRT N/A
- Revenue Next Year
- GROV $6.19
- ASRT $11.20
- P/E Ratio
- GROV N/A
- ASRT N/A
- Revenue Growth
- GROV N/A
- ASRT N/A
- 52 Week Low
- GROV $1.02
- ASRT $0.51
- 52 Week High
- GROV $1.95
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- GROV 30.37
- ASRT 39.17
- Support Level
- GROV $1.07
- ASRT $0.58
- Resistance Level
- GROV $1.41
- ASRT $0.80
- Average True Range (ATR)
- GROV 0.09
- ASRT 0.05
- MACD
- GROV -0.02
- ASRT 0.00
- Stochastic Oscillator
- GROV 22.68
- ASRT 34.48
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.